How tumors escape
Biologists identify extracellular proteins that help aggressive tumors spread through the body.
Resistance is futile
Chemists develop new way to kill cancer cells resistant to the chemotherapy drug cisplatin.
Military medicine
Senior Laura Lu’s years at MIT have included cancer research, ROTC leadership, and prosthesis trials — and she aims to put her talents to use one day as a Navy surgeon.
Keeping an eye on bird flu
MIT studies of two influenza viruses reveal genetic mutations that could result in pandemic flu.
Angela Belcher wins $500,000 Lemelson-MIT Prize
MIT professor honored for her innovations that take cues, and materials, from nature to tackle key societal issues.
Potential flu pandemic lurks
MIT study identifies influenza viruses circulating in pigs and birds that could pose a risk to humans.
Putting the squeeze on cells
By deforming cells, researchers can deliver RNA, proteins and nanoparticles for many applications.
Maria Zuber appointed vice president for research
Claude Canizares will take a new role as a vice president with responsibility for international partnerships.
Getting (drugs) under your skin
Using ultrasound waves, researchers boost skin’s permeability to drugs.
Using the body’s own defenses to combat cancer
By engineering T cells to attack tumors, researchers hope to add a new weapon to their cancer-fighting arsenal.
Why cancer drugs lose their power
MIT biologists show how tumors can become resistant to the commonly used chemotherapy drug cisplatin.